Fulgent Genetics officer proposes $38.4K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Xie Jian, an officer of Fulgent Genetics, Inc. (FLGT), reported a proposed sale of 2,146 common shares, with an aggregate market value of $38,382.27 and an approximate sale date of June 2, 2026. The securities information lists 27,493,435 shares outstanding.
The securities table records an acquisition of 45,304 shares through restricted stock vesting on February 25, 2025, as equity compensation for services rendered. It also lists 1,201 shares sold on May 27, 2026, for gross proceeds of $21,137.57. The remarks state that the proposed sale and sales during the prior three months were to satisfy tax withholding obligations through sell-to-cover transactions, not discretionary trades.
Key Figures
Key Terms
sell to cover financial
Restricted Stock Units financial
tax withholding obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.